IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
J. Allinne (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), A. Agrawal (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), V. Kamat (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America)
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Session: Novel drug targets for asthma and COPD
Session type: Oral Presentation
Number: 1944
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Allinne (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), A. Agrawal (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), V. Kamat (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.. 1944
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: